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Introduction
The J wave syndromes (JWS), consisting of  the Brugada syndrome (BrS) and early repolarization (ER) 
syndrome (ERS), are characterized by accentuated J waves on the electrocardiogram (ECG) and the vulner-
ability to life-threatening ventricular arrhythmias in young adults with no apparent structural heart diseases 
(1). The development of  JWS is attributed to the loss of  function of  the depolarizing currents (such as sodi-
um current INa and L-type calcium current ICa,L) with the concomitant gain of  function of  the repolarizing 
currents (such as transient outward potassium current Ito and adenosine triphosphate sensitive potassium 
current IK-ATP) (1). The imbalanced ion channel dysfunction leads to heterogeneous early repolarization as 
well as depolarization abnormalities and slow conduction, thus facilitating phase 2 reentry (P2R) and ven-
tricular fibrillation (VF) (1). JWS are considered to be genetic ion channelopathies due to the variants found 
in genes encoding these cardiac ion channels as well as other regulatory proteins (1), and also occur in 
acquired conditions, such as hypothermia. A common finding of  both the congenital and acquired JWS 
is reduced INa. Blockers of  INa such as ajmaline and flecainide are commonly used to unmask the BrS (2). 
Hypothermia, which causes J wave elevation (Osborn wave), is also known to be associated with signifi-
cantly reduced peak INa (3, 4). However, genetically engineered pigs that expresses SCN5A E558X variant 
The mechanisms of J wave syndrome (JWS) are incompletely understood. Here, we showed that 
the concomitant activation of small-conductance calcium-activated potassium (SK) current (IKAS) 
and inhibition of sodium current by cyclohexyl-[2-(3,5-dimethyl-pyrazol-1-yl)-6-methyl-pyrimidin-
4-yl]-amine (CyPPA) recapitulate the phenotypes of JWS in Langendorff-perfused rabbit hearts. 
CyPPA induced significant J wave elevation and frequent spontaneous ventricular fibrillation 
(SVF), as well as sinus bradycardia, atrioventricular block, and intraventricular conduction delay. 
IKAS activation by CyPPA resulted in heterogeneous shortening of action potential (AP) duration 
(APD) and repolarization alternans. CyPPA inhibited cardiac sodium current (INa) and decelerated 
AP upstroke and intracellular calcium transient. SVFs were typically triggered by short-coupled 
premature ventricular contractions, initiated with phase 2 reentry and originated more frequently 
from the right than the left ventricles. Subsequent IKAS blockade by apamin reduced J wave 
elevation and eliminated SVF. β-Adrenergic stimulation was antiarrhythmic in CyPPA-induced 
electrical storm. Like CyPPA, hypothermia (32.0°C) also induced J wave elevation and SVF. It 
facilitated negative calcium-voltage coupling and phase 2 repolarization alternans with spatial and 
electromechanical discordance, which were ameliorated by apamin. These findings suggest that IKAS 
activation contributes to the development of JWS in rabbit ventricles.
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identified from a patient with BrS exhibited only conduction defects, but no J wave elevation at baseline or 
after flecainide administration (5). These data suggest that reduction of  INa alone, in the absence of  a signifi-
cant transient outward repolarizing K+ current, does not cause JWS.
Apamin-sensitive small-conductance calcium-activated potassium (SK) current (IKAS) is important in 
cardiac repolarization and arrhythmogenesis in multiple physiological and pathological conditions (6–8). 
Moreover, because its conductance tracks the Ca2+ transient, it behaves functionally like a transient out-
ward K+ current. In recent human studies, genetic polymorphisms of  KCNN3 (encodes SK3) and KCNN2 
(encodes SK2) were found to be associated with atrial fibrillation, ventricular tachyarrhythmias, and sudden 
cardiac death (9, 10). Overexpression of  KCNN3 in mice caused bradycardia, atrioventricular (AV) block, 
and sudden cardiac death (11). Because a correlation between IKAS activation and ventricular arrhythmias 
was discovered just recently in 2011 (6), the relationship between IKAS and JWS has not yet been investi-
gated. Since IKAS is most abundantly activated during the early repolarization phase of  the action potential 
(AP) when ICa,L activity, sarcoplasmic calcium release, and intracellular calcium (Cai) are high, it is reason-
able to hypothesize that IKAS activation could mimic Ito in precipitating arrhythmias seen in JWS.
Cyclohexyl-[2-(3,5-dimethyl-pyrazol-1-yl)-6-methyl-pyrimidin-4-yl]-amine (CyPPA) is the first subtype-
selective SK channel positive modifier (12). It also exhibits inhibitory effects on INa mediated by Nav1.2 
(12), but its effects on cardiac INa remain unclear. Here, we verified that CyPPA inhibits cardiac INa so that 
the effects of  CyPPA are combined with IKAS activation and INa blockade. In this study, we recapitulated 
JWS phenotypes in CyPPA or hypothermia-treated rabbit whole hearts, which manifested with J wave 
elevation and spontaneous ventricular fibrillation (SVF) or spontaneous ventricular tachycardia (SVT), as 
well as conduction abnormalities. We further showed that apamin, a specific IKAS blocker (13), eliminated J 
wave elevation and ventricular arrhythmias.
Results
CyPPA induces JWS. As shown in Figure 1A, neither J wave nor SVF/SVT was observed at baseline. After 
IKAS activation by CyPPA, J point was elevated in all 12 hearts, including 6 type 1 Brugada waves, 2 type 
2 Brugada waves, and 4 ER. SVF or SVT developed in 11 of  12 hearts with a total of  128 episodes, which 
were typically triggered by short-coupled premature ventricular contractions (PVCs, black arrow) (Figure 
1B). Atrial tachycardia and different degrees of  AV block were also commonly observed. Subsequent IKAS 
blockade by apamin attenuated J waves in all hearts. Only 2 episodes of  SVF/SVT occurred after apamin. 
These findings show that IKAS activation is required for the development of  JWS. Figure 1C shows CyPPA 
induced spontaneous variations of  Brugada waves, which were frequently observed in BrS patients. Sum-
mary data in Figure 1D shows that the J point amplitude and the number of  SVF/SVT episodes were 
significantly higher after CyPPA (0.31 ± 0.04 mV and 10.4 ± 4.2) than at baseline (0.07 ± 0.02 mV and 0.0 
± 0.00), but decreased after apamin (0.11 ± 0.06 mV and 0.2 ± 0.1, P < 0.05 for all). Thus, in normal rab-
bit hearts, we recapitulated JWS phenotypes by CyPPA. Excessive IKAS activation is highly proarrhythmic, 
while IKAS blockade is antiarrhythmic.
CyPPA heterogeneously shortens action potential (AP) duration (APD). To understand the mechanisms of  the 
CyPPA-induced JWS, optical mapping was performed to identify the effects of  CyPPA on APD (protocol I). 
As shown in Figure 2A, APD was homogeneous at baseline. CyPPA heterogeneously shortened APD25 at all 
pacing cycle lengths (PCLs) and led to AP triangulation, indicating heterogeneous IKAS activation at the early 
phases of  repolarization. Subsequent apamin addition prolonged both APD25 and APD80, reduced APD 
heterogeneity, and restored the phase 2 plateau of  repolarization. The ΔAPD maps in Figure 2B further 
strengthened the heterogeneous APD shortening after CyPPA and heterogeneous APD prolongation after 
apamin. Compared with the left ventricles (LVs), large ΔAPD zones were more commonly observed in the 
right ventricles (RVs). With small ΔAPD islands scattered inside, RVs harbored more arrhythmogenic sub-
strate with the formation of  steep APD gradients. Figure 2C shows a pseudo-electrocardiogram (pECG) and 
its corresponding Vm traces from different regions. The abbreviated and early repolarized AP at site 1 was 
correlated with J point elevation of  the pECG. Figure 2D summarizes that APD25, but not APD80, was sig-
nificantly abbreviated by CyPPA, while both were significantly prolonged by subsequent apamin at all PCLs.
CyPPA increases AP dynamic instabilities. T wave alternans is associated with VF occurrences in BrS 
patients (14). To test the effects of  CyPPA on repolarization variability, 5 continuous sinus beats were opti-
cally mapped. As shown in Figure 3A, APD exhibited spatiotemporal homogeneity at baseline. After CyP-
PA, AP exhibited increased dispersion with steep APD gradients forming mainly in the RV (red arrow), 
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which changed dynamically from beat to beat. The spatial heterogeneities and temporal instabilities of  AP 
were attenuated by subsequent exposure to apamin. As further shown in Figure 3B, ΔAPD between 2 suc-
cessive beats was minimal at baseline. After CyPPA, ΔAPD increased prominently with beat-to-beat varia-
tions. The large ΔAPD zones (blue or red) were more frequently located in the RV than the LV. Apamin 
reduced the AP discordance and instabilities. These results indicate that IKAS activation is spatiotemporally 
heterogeneous. The steep APD gradient, increased AP dispersions, and dynamic variations suggest height-
ened arrhythmogenicity with IKAS activation, especially in the RV.
Effects of  CyPPA on depolarization, conduction, and calcium transient. In addition to repolarization abnor-
malities, JWS is also associated with abnormal depolarization and conduction delay (15). Therefore, we 
further evaluated the effects of  CyPPA on depolarization, intraventricular conduction, and Cai cycling. 
Compared with baseline, CyPPA significantly decelerated AP upstroke and slowed intraventricular con-
duction velocity (CV) at all PCLs (Figure 4, A and B). Voltage clamp study indicated that CyPPA at 10 
μmol/l inhibited INa in rabbit ventricular myocytes (Figure 4, C and D, Supplemental Figure 1, and Sup-
plemental Table 1; supplemental material available online with this article; https://doi.org/10.1172/jci.
insight.122329DS1). As shown in Figure 4, E and F, CyPPA significantly abbreviated Cai transient duration 
Figure 1. J wave syndrome is induced by CyPPA and suppressed by apamin. (A) pECG during sinus rhythm (protocol I). No J wave was observed at baseline. 
CyPPA accentuated J waves in all 12 hearts with either Brugada or early repolarization (ER) morphologies. Subsequent apamin attenuated J waves in all 
hearts. (B) CyPPA induced spontaneous ventricular fibrillation (SVF) or spontaneous ventricular tachycardia (SVT) in 11 of 12 hearts. SVFs were typically 
triggered by spontaneous short-coupled premature ventricular contractions (PVCs, black arrows). Atrial tachycardia and atrioventricular block were also 
observed. (C) Spontaneous variations of Brugada waves. (D) Summary of the J point amplitude and the episode numbers of SVF/SVT at baseline, after 
CyPPA and after apamin. Statistical significance was determined by 1-way ANOVA with Tukey’s post hoc test.
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(CaiTD25) at all PCLs. Compared with CyPPA, apamin prolonged CaiTD25 at longer PCLs and CaiTD80 at 
all PCLs. These effects on calcium transient in whole hearts were supported by confocal calcium imaging 
in fluo-4AM–loaded isolated ventricular cardiomyocytes, showing increased time to peak and decreased 
decay time after CyPPA, which were prolonged after apamin (Figure 4G).
Arrhythmogenic effects of  CyPPA. We further investigated the properties of  ventricular arrhythmias 
induced by CyPPA. Supplemental Figure 2 displays an example of  pacing-induced P2R after CyPPA, which 
was eliminated by subsequent apamin addition. More importantly, we optically captured SVF or SVT that 
occurred after CyPPA. As shown in Figure 5A, J point was elevated during sinus rhythm before the SVF 
onset. RR intervals gradually shortened due to type 1 (Wenckebach) second-degree AV block. Two episodes 
of  SVF subsequently initiated from spontaneous short-coupled PVCs, which were confirmed in correspond-
ing membrane potential (Vm) traces (Figure 5B). The Vm map of  beat 1 (Figure 5C) exhibited an extremely 
steep APD gradient, providing an enhanced arrhythmogenicity prior to the onset of  SVF. The phase map of  
Figure 2. Effects of CyPPA and apamin on action potential duration (APD). (A) Overlapped Vm traces and representative APD25 and APD80 maps at 
baseline, after CyPPA and after apamin with right ventricular (RV) pacing at pacing cycle length (PCL) 280 ms, 300 ms, and 350 ms (protocol I, n = 12). APD 
exhibited homogeneity at baseline. CyPPA heterogeneously shortened and triangulated APD at all PCLs. The heterogeneity was more severe in the RVs 
than the left ventricles (LVs). Apamin prolonged APD and restored AP plateau and APD homogeneity. LAD indicates left anterior descending artery. (B) 
ΔAPDBaseline–CyPPA and ΔAPDApamin–CyPPA maps display heterogeneous APD shortening after CyPPA and heterogeneous prolongation after apamin. Large ΔAPD 
areas (red, orange, or yellow zones) were more likely distributed in the RV with small ΔAPD spots (green dots marked with °) scattering inside, thus form-
ing a steep APD gradient. (C) pECG and corresponding optical traces recorded at different sites. (D) Summary of APD25 and APD80 at baseline, after CyPPA 
and after apamin in all 3 PCLs. Data represent mean ± SEM. Statistical significance was determined by 2-way ANOVA with Bonferroni’s post hoc test.
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beat 3 (Figure 5D) shows wavebreaks that degenerated into reentry in the RV. Figure 5, E–G display another 
episode of  SVF with P2R initiation that was directly triggered by a sinus beat. The first phase singularity 
(PS) that was generated by wavebreaks formed in the RV. The transmembrane potential (TMP) recording in 
Figure 5H shows the development of  phase 2 early after depolarization in the right ventricular outflow tract 
(RVOT). The onset of  the AP in the RVOT occurred 17 ms prior to the QRS complex in the ECG, while 
AP onset in the LV occurred 28 ms after the onset of  the QRS, also indicating the RV initiation. In addition, 
simultaneously optical mapping at 2 epicardial sites and 1 endocardial site from the RV (Figure 5I) shows 
that P2R was initiated between 2 epicardial sites and propagated to the endocardial site, suggesting a more 
important role of  epicardium than endocardium in arrhythmogenicity.
The more important role of  RV in arrhythmogenicity was further demonstrated in Supplemental Fig-
ure 3. The first PS of  SVF and the PSs presented in the first 300 ms of  SVF were more frequently distributed 
in the RV than in the LV. In addition to SVF, nonsustained ventricular tachycardia (NSVT) also commonly 
developed after CyPPA (Supplemental Figure 4).
Figure 3. CyPPA induces dynamic action potential (AP) variations during sinus rhythm. (A) Representative Vm traces, APD25 and APD80 maps of 5 con-
tinuous sinus beats at baseline, after CyPPA and after apamin (protocol I). APD at baseline was homogeneous with dynamic stability. CyPPA led to hetero-
geneous APD distribution with beat-to-beat AP variations. Red arrow indicates the steep APD gradient forming in the right ventricle. Subsequent apamin 
administration diminished the spatial heterogeneity and dynamic instability. (B) ΔAPD25 and ΔAPD80 maps show the differences between 2 successive 
beats. Note that dynamic APD changes were minimal at baseline and after apamin. CyPPA led to strengthened beat-to-beat APD instability.
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Activation of  SK3, not SK2, is responsible for CyPPA-induced JWS. As a subtype-selective SK positive modula-
tor, CyPPA at 10 μmol/l mainly activates IKAS carried by SK3 (12). To further differentiate the effects of SK3 
from SK2, rabbit hearts were pretreated with Lei-Dab 7 (15 nmol/l), a specific SK2 blocker with little effect 
on SK3 (16), prior to CyPPA (protocol IIA, Supplemental Figure 5). SK2 blockade by Lei-Dab7 pretreatment 
failed to prevent J wave elevation and SVF induced by CyPPA. However, subsequent SK3 blockade by apamin 
suppressed JWS and heterogeneously prolonged APD, indicating that SK3 activation is responsible for JWS. 
This was confirmed by the control studies in which apamin was administered prior to CyPPA (protocol IIB, 
Figure 4. Effects of CyPPA and apamin on depolarization, conduction, and Cai transient. (A) Representative Vm traces and activation (AT) maps at pacing 
cycle length (PCL) 300 ms (protocol I, n = 12). Compared with baseline, CyPPA decelerated action potential (AP) upstroke and intraventricular conduction 
velocity (CV). Subsequent apamin had little effect on AP upstroke and CV. (B) Summary of the Vm time to peak (Tpeak) and CV at baseline, after CyPPA and 
after apamin (mean ± SEM, 2-way ANOVA with Bonferroni’s post hoc test). (C) Voltage clamp of sodium current (INa) in isolated ventricular cardiomyocytes. 
Superimposed current traces of INa obtained in the absence (control) and presence of CyPPA (10 μmol/l). (D) Average I-V relationships of INa density in the 
absence (black) and presence of CyPPA (red) (mean ± SEM, n = 12 myocytes from 4 rabbits). (E) Representative Cai traces, Cai transient duration (CaiTD25) 
and CaiTD80 maps at PCL 300 ms. CyPPA abbreviated CaiTD25 and CaiTD80, while apamin prolonged CaiTD25 and CaiTD80 due to slow Cai transient decay. (F) 
Summary of CaiTD25 and CaiTD80 at baseline, after CyPPA and after apamin (mean ± SEM, 2-way ANOVA with Bonferroni’s post hoc test). (G) Confocal 
calcium imaging in fluo-4AM–loaded isolated ventricular cardiomyocytes with field stimulation at 0.5 Hz. Left panel: original fluorescence signal. Right 
panel: F/F0 traces of intracellular Ca
2+ dynamics.
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Supplemental Figure 6). With apamin pretreatment blocking both SK2 and SK3, CyPPA failed to induce J 
wave elevation. Although PVCs were still frequently observed, none of them degenerated into SVF. In the pres-
ence of apamin, CyPPA prolonged APD due to delayed AP upstroke by INa blockade.
Sex and regional differences. As shown in Supplemental Figure 7, males had significantly higher CyPPA-
induced J wave elevation (ΔJ point amplitude: 0.27 ± 0.07 mV vs. 0.21 ± 0.02 mV, P < 0.05) and more 
episodes of  SVF/SVT (16 ± 8 vs. 5 ± 1, P < 0.001) than females. Electrical storm (ES) only developed in 
males. However, the differences in ΔAPD were insignificant between sexes. The differences in the quantita-
tive PCR (qPCR) measurements of  SK3 mRNA expression (normalized to GAPDH, ×100) among tissue 
preparation of  male RVOT, male LV base (LVB), female RVOT, and female LVB were also insignificant.
Therapeutic approaches for CyPPA-induced JWS. As shown above, IKAS blockade by apamin is antiarrhyth-
mic in CyPPA-treated rabbit hearts. Supplemental Figure 8 exhibits another typical case of  ES induced by 
CyPPA in a male rabbit. SVF was originated from RVOT (site 1) and the reentry traveled along the path of  
1-4-5-2-1. In contrast, ES was terminated after apamin despite frequent spontaneous PVCs. The PVC was 
originated from the similar region at RVOT (site 1) but failed to complete the reentry.
Since isoproterenol suppresses ES in BrS clinically (17), we tested the effects of  isoproterenol on CyP-
PA-induced JWS (protocol IV, n = 6). Isoproterenol eliminated SVF in all 6 hearts. As shown in Figure 6A, 
J wave was accentuated and an episode of  SVF developed after CyPPA. A total of  8 shocks were applied to 
attempt to defibrillate. The first 7 shocks failed according to ECG, but the eighth attempt succeeded. After 
isoproterenol, J wave was slightly attenuated and no SVF developed. Two episodes of  VF were induced by 
ventricular pacing. The first episode was successfully defibrillated by shock 9, while the second episode was 
self-terminated. Figure 6B shows that during sinus rhythm after CyPPA, both APD25 and APD80 exhibited 
heterogeneous dispersions with large gradients, especially in the RV. The activation map displayed impaired 
intraventricular conduction. After isoproterenol, APD25 and APD80 were markedly shortened but became 
Figure 5. CyPPA induces spontaneous ventricular fibrillation (SVF) by phase 2 reentry (P2R). (A–D) Representative SVF episodes initiated by sponta-
neous short-coupled premature ventricular contractions (PVCs) after CyPPA. (A) pECG shows that before the onset of SVF, J wave was elevated and RR 
interval was gradually shortened due to type I (Wenckebach) second-degree AV block. (B) Corresponding Vm traces shows P2R. (C) Vm map of beat 1 exhibits 
steep action potential duration (APD) gradient prior to the onset of SVF. (D) Phase map of beat 3 shows wavebreaks that degenerated into reentry. (E–G) 
An episode of SVF was directly initiated from a sinus beat after CyPPA. (E) pECG. (F) Corresponding Vm map shows P2R. (G) Phase map of beat 2 shows 
wavebreaks which degenerated into reentry in the RV. (H) Simultaneous ECG and transmembrane potential (TMP) recordings at the onset of SVF. The TMP 
recorded from a ventricular cardiomyocyte at RVOT exhibits phase 2 early afterdepolarization. The action potential onset in the right ventricular outflow 
tract (RVOT) occurred 17 ms prior to the QRS complex, while action potential onset in the left ventricle (LV) occurred 28 ms after the onset of QRS complex. 
Black vertical line indicates the QRS onset. (I) Simultaneous optical traces at 2 epicardial sites and 1 endocardial site from the RV at the onset of SVF. P2R 
was generated between 2 RV epicardial sites and propagated to the endocardial site, thus precipitating SVF.
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more homogeneous with accelerated conduction velocity. Figure 6C shows optical traces at the time of  
defibrillation. During CyPPA, the apparent shock-resistant VF on ECG was actually successfully defibril-
lated. However, P2R was immediately re-initiated after only 1 sinus beat, such that VF seemed sustained on 
ECG. After isoproterenol, the pacing-induced VF was successfully defibrillated without reinitiation. These 
results indicate that isoproterenol is antiarrhythmic in CyPPA-induced JWS.
IKAS activation induces Osborn waves and phase 2 repolarization alternans during hypothermia. Environ-
mental factors can also lead to the appearance of  ECG patterns and arrhythmias similar to JWS in 
the absence of  any apparent genetic abnormality. Among a variety of  acquired conditions, classical J 
waves are induced by hypothermia, also known as Osborn waves. As hypothermia reduced INa (3, 4), 
we hypothesized that IKAS is concomitant activated during hypothermia, and thus contributes to the 
generation of  Osborn waves. We created hypothermia (32.0°C), followed by apamin administration 
(at 32.0°C) and rewarming (38.3°C) in 6 hearts (optical mapping, protocol IV). Osborn waves were 
induced in 5 hearts and were attenuated by subsequent apamin in 3 hearts. SVF was developed in 2 
hearts during hypothermia (1 episode for each), while no SVF was observed after apamin (Figure 7, 
A and B). The results from ex vivo pECG recordings were verified by in vivo surface ECG studies 
in 2 rabbits (Supplemental Figure 10), which also showed that IKAS inhibition by apamin suppressed 
Osborn waves in both rabbits.
Optical mapping data in Figure 7C show that, compared with baseline, APD prolonged during hypo-
thermia, which might be correlated with the increased Cai transient. IKAS blockade by apamin further 
prolonged APD more prominently at APD25 than at APD80, suggesting IKAS activation at early repolariza-
tion phases. After rewarming, CaiTD and APD were shortened towards baseline. We further performed 
rapid ventricular pacing to induce Cai and Vm alternans. As shown in Supplemental Figure 9, at baseline 
with normothermia, Cai and Vm were positively coupled and exhibited spatial concordance. However, dur-
ing hypothermia (Figure 7D), Cai and Vm became negatively coupled (electromechanically discordant) at 
Figure 6. Isoproterenol is antiarrhythmic in CyPPA-induced J wave syndrome. Protocol III (n = 6). (A) pECG after CyPPA (upper panel) shows J wave 
elevation during sinus rhythm and an episode of spontaneous ventricular fibrillation (SVF). The SVF was shock resistant (shocks 1–7), which was 
defibrillated by the eighth attempt of shock (shock 8). After isoproterenol infusion (lower panel), J wave was slightly attenuated and no SVF was 
generated. Ventricular pacing induced 2 episodes of VF. The first episode was defibrillated by the first attempt (shock 9). The second episode was 
self-terminated. (B) Optical maps during sinus rhythm. During CyPPA, action potential duration (APD25) and APD80 maps exhibited heterogeneous APD 
distribution and large APD gradient, especially in the right ventricle. The activation (AT) map shows slow intraventricular conduction. Subsequent iso-
proterenol markedly shortened APD25 and APD80, diminished APD heterogeneities, and accelerated conduction velocity. (C) Simultaneous optical traces 
of Cai and Vm at the time of defibrillation. During CyPPA, the shock-resistant VF on ECG was actually successfully defibrillated by shock 1. However, 
phase 2 reentry was immediately reinitiated after 1 sinus beat, such that VF appeared to sustain on pECG. After isoproterenol, the pacing-induced VF 
was successfully defibrillated by the first attempt (shock 9) without reinitiation.
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distal sites (site 2 and 3) but remained positively coupled at the proximal site (site 1), leading to spatially 
discordant Vm alternans. The difference between 2 consecutive beats (beat 2 – beat 1) was larger at APD25 
than at APD80, indicating alternans was more prominent at early repolarization phases. IKAS blockade by 
apamin differentially prolonged APD at APD25 and APD80 and in beat 1 and beat 2. The prolongation was 
more prominent at beat 1 coupled to the larger Cai transient than at beat 2 coupled to the smaller Cai tran-
sient, and was more prominent at APD25 when Cai was higher than that at APD80. As a result, negative 
Cai-Vm coupling was eliminated and phase 2 alternans was attenuated. Taken together, our results show 
that IKAS is activated during hypothermia and participates in the generation of  Osborn waves. IKAS blockade 
may serve as a potential therapeutic approach for preventing ventricular arrhythmia during hypothermia.
Discussion
IKAS activation with concomitant INa inhibition by CyPPA recapitulates JWS in Langendorff-perfused rabbit 
hearts. CyPPA also causes sinus bradycardia, atrial tachyarrhythmias, AV block, and intraventricular conduc-
tion delay, which have been observed in BrS (18). We summarized the manifestations of  clinical BrS, ERS, 
and the CyPPA-induced JWS models in Supplemental Table 2. There are significant similarities among them.
Figure 7. IKAS activation induces Osborn waves and phase 2 repolarization alternans during hypothermia. Protocol IV (n = 6). (A) ECG of sinus rhythm shows 
Osborn waves during hypothermia, which was attenuated by apamin. (B) During hypothermia before apamin, an episode of spontaneous ventricular fibrilla-
tion was triggered by a spontaneous short-coupled premature ventricular contraction. (C) Optical maps of Cai and Vm at pacing cycle length 300 ms. Compared 
with baseline, hypothermia prolonged both Cai transient duration (CaiTD) and action potential duration (APD). Apamin had limited effect on CaiTD, but further 
prolonged APD more prominently at APD25 than at APD80. After rewarming, CaiTD and APD were shortened towards baseline. (D) During hypothermia, Cai 
and Vm alternans were induced by ventricular pacing at 200 ms. Before apamin, Cai and Vm were negatively coupled at distal sites (site 2 and 3) but remained 
positive coupling at proximal sites (site 1), leading to spatially discordant Vm alternans. The difference between 2 consecutive beats (beat 2 – beat 1) was larger 
at APD25 than at APD80 (phase 2 repolarization alternans). Apamin differentially prolonged APD at APD25 and APD80 and in beat 1 and beat 2. The prolongation 
was more prominent in beat 1, which coupled with larger Cai transient than in beat 2 coupled with smaller Cai transient, and more prominent at APD25 when Cai 
was more abundant than at APD80. As a result, apamin eliminated the negative Cai-Vm coupling and attenuated phase 2 repolarization alternans. 
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CyPPA and SK3 activation. CyPPA is the first subtype-selective potentiator of SK3 channels (SK3 > SK2 
>>> SK1) (12). It does not activate Ca2+ and other voltage-dependent K+ currents; however, it causes an inhibi-
tion of BK and Na+ currents (12). CyPPA binds to and allosterically modulates via a binding pocket situated 
at the intracellular interface of SK and calmodulin, which increases the SK/calmodulin’s affinity for Ca2+ (19). 
Due to overlapping activation ranges between SK3 (EC50 = 5.6 ± 1.6 μmol/l) and SK2 (EC50 = 14 ± 4 μmol/l) 
and the possibility of forming heteromeric complexes (20, 21), whether CyPPA at the current concentration 
can activate heteromeric channels remains unclear. However, SK2 and SK3 activation might lead to different 
manifestations. While overexpression of SK2 resulted in tachycardia and increased AV node conduction (22), 
overexpression of SK3 led to bradycardia, conduction disturbances, and ventricular APD dispersion, resulting 
in sudden cardiac death (11, 23). The latter finding mimicked the phenotypes observed in this CyPPA model of  
BrS. The dominance of SK3 activation was also supported by the ability for CyPPA to induce JWS after pre-
treatment with SK2-specific blocker Lei-Dab 7, but prevention of JWS after treatment with apamin (Supple-
mental Figures 5 and 6). Therefore, we propose that the development of JWS is mainly attributed to SK3 rather 
than SK2 activation. Because CyPPA exclusively increases the Ca2+ sensitivity of SK3 activation without effect 
on maximally activated channels (12), the results of this study suggest that modulation of SK3 channel Ca2+ 
sensitivity could be an endogenous mechanism for fine-tuning cardiac repolarization and arrhythmogenesis.
IKAS activation and arrhythmogenesis. IKAS is minimally activated in normal rabbit ventricles and is upregu-
lated and antiarrhythmic when repolarization reserve is impaired, such as in heart failure and hypokalemia 
(24, 25). Because normal rabbit hearts already exhibit abundant repolarization reserve, as we proposed here, 
with concomitant INa inhibition, excessive IKAS activation in normal hearts is highly arrhythmogenic by induc-
ing early and heterogeneous repolarization, especially in the RV epicardium. These findings are consistent 
with the heterogeneity of  repolarization within the RVOT epicardium in patients of  BrS receiving pilsicainide 
challenge (26). Since CyPPA increases IKAS sensitivities to Ca
2+, in some regions, the excessive activation of  
IKAS counterbalances the APD-prolonging effects of  Ca
2+ influx, resulting in the loss of  AP domes and early 
repolarization. In other regions, however, IKAS activation drives the membrane voltage into the window with 
delayed ICa,L inactivation. The enlarged calcium window current overwhelms the outward currents, leading to 
a prominent AP dome and prolonged APD. The electrophysiological heterogeneity creates a large electrical 
gradient between regions, thus facilitating P2R. P2R related to Ito is thought to originate primarily from the 
epicardium (27), which is in line with our observations in Figure 5D with IKAS activation. However, since epi-
cardium expresses significantly more IKAS than the mid-myocardium layer in both human and rabbit ventricles 
(6, 28), the transmural heterogeneity of  IKAS might also contribute to the arrhythmogenesis.
A previous experimental study in canines showed that enhanced Ito caused APD alternans (29), which 
was later confirmed by computer simulations (30). Ito-mediated alternans or other complex AP dynamics 
(such as chaos) are associated with unstable switching AP morphology even in homogeneous cables, which 
underlies P2R formation (31). In the present study, irregular alternans or chaos (Figure 3) is potentiated by 
IKAS activation, suggesting that IKAS could act like Ito in AP dynamics. In addition to spatial heterogeneity 
due to different anatomical properties or fibrosis in RVOT (15), our data suggest that dynamic instability is 
also important in the arrhythmogenesis of  JWS.
IKAS is an important coupler between Cai and Vm due to its Ca
2+ sensitivity (32). Cai and Vm are posi-
tively coupled (i.e., a large Cai transient prolongs and a small Cai transient shortens APD) in the absence of  
IKAS (32). Mathematically introducing IKAS could shorten APD when Cai transient is large, which results in 
negative Cai-Vm coupling (32). In this study, we experimentally validated this prediction in the hypothermia 
model. During hypothermia, the decreased peak ICa,L reduces Ca
2+-dependent ICa,L inactivation and prolongs 
Cai transient, which in turn increases sarcoplasmic Ca
2+ stores and release (33). IKAS is more abundantly acti-
vated at early repolarization phases and at the beat with larger Cai transient, leading to faster phase 2 repolar-
ization (shorter APD25 and AP triangulation), while IKAS is less abundantly activated at the beat with smaller 
Cai transient, leading to slower phase 2 repolarization (longer APD25 and AP squaring). In this situation, the 
coupling between Cai transient and APD25 turns into negative, resulting in phase 2 repolarization alternans 
with electromechanical discordance, especially at regions distal to the pacing site that harbor enriched Ca2+ 
accumulation and IKAS activation (24). IKAS blockade by apamin prominently prolongs APD at the beats with 
large IKAS activation, at early repolarization phase, and at regions distal to the pacing site, and thus attenuates 
negative Cai-Vm coupling at early repolarization phase and its spatial discordance. We propose that phase 2 
repolarization alternans facilitates P2R. IKAS blockade prevents hypothermic ventricular arrhythmias by the 
attenuation of  the spatially and electromechanically discordant phase 2 repolarization alternans.
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Clinically, bradycardia and conduction delay are commonly observed in BrS (15). In this CyPPA mod-
el, AV node and intraventricular conduction are also impaired. Since CyPPA at 10 μmol/l reduces peak INa 
by approximately 60% in ventricular myocytes, these effects on cardiac conduction as well as the decreased 
AP upstroke velocity are attributed, at least partially, to INa blockade. However, the slow conduction seems 
large given the degree of  INa blockade. One possible explanation is that large APD heterogeneity leads to 
heterogeneity of  refractory period, which impairs conduction velocity (postrepolarization refractoriness). 
A second reason is that SK channels are abundantly present in intercalated discs (28). Mice with SK3 
overexpression develop conduction block (11), suggesting that IKAS may directly participate in the cardiac 
conduction. Additionally, conduction does not only rely on the coupling between myocytes, but also on 
the Purkinje system and the coupling between Purkinje cells and cardiomyocytes. It is possible that the 
CyPPA reduces INa more in Purkinje cells than ventricular cardiomyocytes. Finally, IKAS density is larger in 
the Purkinje system than cardiomyocytes (34). It is possible that slow conduction is caused by INa inhibition 
and IKAS activation in the His-Purkinje system. We also observed slow upstroke of  Ca
2+ transient induced 
by CyPPA (Figure 4E). Since CyPPA blocks INa, the slow upstroke of  Ca
2+ transient is probably secondary 
to the slow depolarization. The slow depolarization leads to decreased activation of  L-type Ca2+ current, 
which further results in insufficient Ca2+-induced Ca2+ release from the sarcoplasmic reticulum. The slow 
Ca2+ upstroke was also observed in the induced pluripotent stem cell–derived cardiomyocytes from BrS 
patients with SCN5A mutation (35). Since depolarization and repolarization are never independent, the 
IKAS-mediated concomitant effects of  early repolarization and dysfunction of  depolarization and conduc-
tion might reveal the potential mechanisms contributed to JWS.
Genetic basis and acquired conditions. JWS are considered genetic diseases. BrS and ERS have been 
associated with variants in 18 and 7 genes, respectively (1). However, these genetic variants accounted for 
only one third of  JWS patients (1). It is possible that gain-of-function mutations in KCNN3 could directly 
increase IKAS and facilitate the development of  JWS. Single-nucleotide polymorphisms and other variants 
in KCNN3 should be evaluated in future genetic scanning. In addition, IKAS activation by CyPPA and its 
affinity for Ca2+ are regulated by a number of  coassembled modulator proteins, including calmodulin, 
casein kinase 2, and phosphatidylinositol bisphosphate (36). Genetic variants in these SK modulators may 
promote the development of  JWS. More importantly, in BrS patients who carry SCN5A or other sodium 
channel loss-of-function mutations, the activation of  IKAS by drugs or other environmental factors might 
largely increase their vulnerabilities to lethal cardiac arrhythmias. On the other hand, we also demonstrated 
the contribution of  IKAS activation to hypothermic J wave and proarrhythmia. Taken together, the results of  
our study suggest that IKAS might play important roles in either genetic or acquired JWS.
Therapeutic approaches. By prolonging early repolarization phases and reducing AP dispersion and 
dynamic instability, apamin suppresses J wave and SVF, suggesting IKAS blockade as a potential therapeutic 
approach for JWS. Unfortunately, apamin cannot be used clinically due to its neurotoxicity. AP14145, a 
newly synthesized IKAS negative modulator (37), might be a promising candidate for future use in JWS. 
Amiodarone suppresses IKAS at its therapeutic concentration (10–20 μmol/l) (38). However, it has INa block-
ing properties. Recently, we showed that ondansetron is an IKAS blocker (39). Whether or not it is useful in 
managing JWS remains unknown. Further research to develop cardioselective and SK3 subtype-specific 
IKAS blockers may have promise as an antiarrhythmic strategy in JWS. 
The β-adrenergic agonist isoproterenol has a class IIa recommendation for BrS patients presenting 
with recurrent ES (1). In this study, isoproterenol ameliorated CyPPA-induced ES. Since isoproterenol 
augments ICa,L and subsequent RyR Ca
2+ release, isoproterenol alone would activate IKAS. In comparison, 
CyPPA increases the sensitivity of  SK channel to Ca2+ without increasing the maximal activated IKAS con-
ducted by SK3. Notably, CyPPA even induces a small reduction of  the current conducted by SK2 at high 
Ca2+ concentrations. It is possible that IKAS is already abundantly activated by CyPPA, especially at early 
repolarization phases when Ca2+ is high. Therefore, with CyPPA pretreatment, IKAS might respond weakly 
to the further increase of  Ca2+. In contrast, isoproterenol increases and rebalances multiple Ca2+ currents 
such as IKs and chloride currents, which may explain the further shortening of  APD. Isoproterenol also 
augments INa (40), and thus increases the conduction velocity and decreases the heterogeneity of  action 
potential. Both of  these actions may be antiarrhythmic.
Limitations. While we showed that CyPPA could induce JWS in rabbits, whether or not IKAS activa-
tion can cause human JWS remains unclear. Due to the very limited availability of  human heart tissue, 
especially with BrS, it is challenging to directly perform experiments in humans. However, the rabbit model 
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is considered a good animal model for studying cardiac ion currents relevant to humans (41). Because we 
were not able to measure the absolute values of  the action potential, it is unclear if  IKAS activation changed 
the resting membrane potentials of  the hearts studied. However, given the high inward rectifier K+ conduc-
tance due to IK1 in rabbit ventricles, it is unlikely that IKAS during diastole would significantly affect resting 
potential. The Langendorff-perfused hearts do not have intact autonomic innervation. Therefore, we are 
not able to determine the importance of  the autonomic nervous system in the arrhythmogenesis in JWS.
Methods
Animals. A total of  52 adult (5–6 months old at the time of  euthanasia) New Zealand White rabbits (28 
males) with body weight 2.7 to 3.5 kg were used in this study. Among them, 32 (18 males) were used for 
optical mapping, 4 (2 males) were used for TMP recording, 10 (5 males) were used for qPCR, 4 (2 males) 
were used for ventricular cardiomyocytes isolation followed by patch clamp study and confocal calcium 
imaging, and 2 (1 male) for in vivo surface ECG recording.
Ex vivo studies. Rabbits were euthanized by i.v. sodium pentobarbitone overdose (160 mg/kg, i.v.). 
Hearts were harvested and Langendorff  perfused with Tyrode’s solution (in mmol/l: 128.3 NaCl, 4.7 KCl, 
20.2 NaHCO3, 0.4 NaH2PO4, 1.8 CaCl2, 1.2 MgSO4, 11.1 glucose, and 40 mg/l bovine serum albumin 
[BSA]) that was bubbled with 95% O2/5% CO2 to maintain a pH of  7.40. All chemicals were purchased 
from Sigma-Aldrich.
pECG recording. pECG was simultaneously recorded during the optical mapping and the TMP 
recording. In the tissue bath, 2 electrodes were placed close to the right atrium (RA) and the apex of  LV, 
respectively, while the third electrode was used as ground (Supplemental Figure 11A). The signals were 
filtered with a bandpass from 0.5 Hz to 150 Hz with sampling rate 1,000 Hz. A representative pECG at 
baseline is shown in Supplemental Figure 11B. We defined the terms of  pECG morphology as follows 
(Supplemental Figure 11C):
J wave: an elevation of  the QRS-ST junction exceeding 0.1 mV above the baseline level, including 
Brugada wave and ER wave.
Type 1 Brugada wave: a coved-type ST elevation greater than 0.2 mV followed by a gradually descend-
ing ST segment.
Type 2 Brugada wave: a saddle-back ST elevation greater than 0.2 mV followed by a convex ST greater 
than 0.1 mV.
ER: J wave greater than 0.1 mV, excluding type 1 and type 2 Brugada waves.
In addition, JWS was defined as a combination of  J wave and the development of  SVF or SVT. ES was 
defined as at least 10 recurrent episodes of  SVF/SVT during the experiment.
Optical mapping. Simultaneous optical mapping of  Cai and Vm was performed using techniques similar 
to that reported elsewhere (42). The hearts were stained with Rhod-2 AM (1.4 μmol/l, from Invitrogen) 
for Cai mapping and RH237 (10 μmol/l, from Invitrogen) for Vm mapping. Blebbistatin (15–20 μmol/l, 
from Tocris Bioscience) was used to inhibit contraction. The hearts were excited with a laser (Verdi G5, 
Coherent Inc.) at a wavelength 532 nm. The fluorescence was recorded with 100 × 100 pixels for a spatial 
resolution of  0.35 × 0.35 mm2 per pixel at 2 ms/frame sampling rate. Optical signals were processed with 
both spatial (3 × 3 pixels Gaussian filter) and temporal (3 frames moving average) filtering.
Mapping protocol. Four different protocols were used and are listed below. Among them, protocol I was 
performed to test if  IKAS activation by CyPPA (10 μmol/l) induces JWS and if  IKAS blockade by apamin (100 
nmol/l) is antiarrhythmic. In protocol II, we aimed to differentiate the effects of  IKAS carried by different SK 
channel isoforms. Apamin (100 nmol/l) blocked IKAS conducted by both SK2 and SK3, while Lei-Dab 7 at 
15 nmol/l (a highly specific SK2 blocker; ref. 16) only specifically blocked IKAS carried by SK2. In protocol 
III, isoproterenol (100 nmol/l) was applied to test if  this clinical therapeutic approach for BrS is effective 
in the CyPPA-induced JWS model. Protocols I–III were performed at 38.3°C, which is the normal body 
temperature of  rabbits (43). In protocol IV, hypothermia (32.0°C) was created to test the participation of  
IKAS in acquired JWS. A previous study showed that IKAS is upregulated in hypothermia (44).
When comparing APD among baseline and after each treatment, we paced the RV or LV at fixed 
PCL (S1S1) to avoid rate-dependent APD changes. The slowest pacing rate is limited by the competing 
sinus or escape rates of  the Langendorff-perfused hearts. At baseline before CyPPA, the sinus cycle length 
was approximately 320–400 ms. It was not possible to consistently pace the ventricles with PCL longer 
than the sinus cycle length. Similarly, CyPPA impaired AV conduction and induced premature beats. 
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Therefore, it was difficult to perform atrial pacing or ventricular pacing at PCL shorter than 250 ms to 
stably achieve 1:1 AV conduction or 1:1 ventricular capture. Therefore, we chose to compare APD at 3 
PCL: 250 ms, 280 ms, and 300 ms.
To observe spontaneous arrhythmias, we left the ventricles unpaced except during APD measurements. 
In some cases, P2R occurred during APD measurement with S1S1 pacing (Figure 6 after isoproterenol 
and Supplemental Figure 2). All other arrhythmia episodes occurred spontaneous during sinus or escape 
rhythm without pacing. We did not use programmed stimulation to induce arrhythmias. In all protocols, 
the drugs were sequentially added and recirculated in the perfusate.
Protocol I: Baseline- CyPPA- apamin in 14 hearts (8 males). Epicardial mapping with baseline- CyPPA- 
apamin in 12 hearts (6 males). Two additional males were simultaneously mapped at the epicardium and 
the endocardium of  the RV. For the epicardial mapping, optical signals were obtained from the anterior 
surface of  the heart including both the RV and the LV. For simultaneous epicardial and endocardial map-
ping, we made the RV flap preparation as previously described (45). To expose the endocardium, the right 
ventricular posterior wall was cut open and the RV flap was then created by cutting the posterior end of  
the RV free wall from the base to the apex along the posterior descending artery. Major arterial leaks were 
ligated to ensure continuous perfusion of  the RV free wall. After baseline measurement, CyPPA was added 
to the perfusate. APD measurement was performed 10 minutes after CyPPA administration. Optical map-
ping was also attempted to capture the onset of  SVF or SVT. Any VF or VT occurrence was allowed to 
continue for at most 180 seconds before electrical defibrillation. We also performed optical mapping during 
the defibrillation. Apamin was subsequently added to the perfusate in the presence of  CyPPA recirculation. 
Fifteen minutes after apamin administration, another set of  data was collected.
Protocol II: Epicardial mapping of  both the RV and the LV. Protocol IIA: baseline- LeiDab7- CyPPA- 
apamin in 3 hearts (2 males). Protocol IIB: in a changed sequence of  agents as baseline- apamin- CyPPA 
in 3 hearts (2 males).
Protocol III: Epicardial mapping of  both the RV and the LV with baseline- CyPPA- isoproterenol in 6 
hearts (3 males).
Protocol IV: Epicardial mapping of  both the RV and the LV with baseline (38.3°C)- hypothermia 
(32.0°C)- apamin (at 32.0°C)- rewarming (38.3°C) in 6 hearts (3 males). After baseline optical measure-
ment at 38.3°C, the temperature of  the perfusate was decreased to 32.0°C. The heart surface temperature 
was also measured to confirm the creation of  hypothermia. The hypothermia was maintained stably at 
32.0°C ± 0.5°C for 15 minutes before the optical measurement. Apamin was subsequently added into the 
perfusate and recirculated at 32.0°C. Fifteen minutes after apamin, another set of  data was collected. The 
heart was then rewarmed to 38.3°C. We paced the ventricle at PCL 300 ms for APD comparisons, at 150 
ms for alternans induction at baseline, and 200 ms for alternans induction during hypothermia.
TMP recording. The TMP was recorded at the RVOT and the LV during CyPPA (10 μmol/l) administra-
tion in 4 hearts (2 males). After immobilization of  the Langendorff-perfused hearts by blebbistatin, stan-
dard glass capillary microelectrodes filled with 3 mol/l KCl with a tip resistance of  approximately 20 MΩ 
at a digitization rate of  10 kHz was used to record TMP. The data were acquired with an Axoscope 10.2 
(Axon Instruments Inc.). The onset of  SVF after CyPPA was recorded simultaneously by TMP and pECG. 
Experiments were performed at 38.3°C.
Ventricular cardiomyocyte isolation. In order to perform patch clamp and confocal calcium imaging studies, 
ventricular cardiomyocytes were isolated according to previously descried methods (24). Briefly, after the 
sacrifice of  rabbits, the hearts were rapidly excised and Langendorff  perfused with oxygenated Tyrode’s solu-
tion containing (in mmol/l): 138 NaCl, 5.33 KCl, 0.33 NaH2PO4, 1.18 MgCl2, 10 HEPES, 10 taurine, and 10 
glucose, pH 7.4 (NaOH), at 37°C. After rinsing off  remaining blood, the heart was perfused for 7–12 minutes 
with Tyrode’s solution containing liberase (15 μg/ml, Roche). Ventricles were then removed and the epicar-
dium/subepicardium layers were carefully separated and minced into small pieces followed by dispersion 
with a large-bore glass pipette. The dispersed tissue was filtered through 100-μm nylon mesh followed by cen-
trifuging at 500 rpm for 2 minutes at room temperature. The supernatant was removed and the myocytes were 
resuspended in Tyrode’s solution containing 0.2 mmol/l CaCl2 and 1% BSA. The centrifugation was repeated 
and the myocytes were resuspended in Tyrode’s solution containing 0.5 mmol/l CaCl2 and 1% BSA until use.
Patch clamp studies to determine the effects of  CyPPA on INa. A whole-cell patch clamp technique was per-
formed as described elsewhere (46). Briefly, the isolated ventricular cardiomyocytes were superfused with 
bath solution containing (in mmol/l) 137 NaCl, 5.4 KCl, 1.0 CaCl2, 0.5 MgCl2, 10 glucose, and 10 HEPES, 
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pH 7.4. Patch pipette resistances varied from 2.5 to 3.0 MΩ when they filled with an internal solution con-
taining (mmol/l) 20 CsCl, 110 Cs-aspartate, 0.5 MgCl2, 5 MgATP, 0.5 EGTA, and 10 HEPES, pH 7.2 by 
CsOH adjustment. While INa recording, K
+ in pipette solution was replaced with equal molar amounts of  
Cs+. Voltage protocol and data acquisition were controlled by Axopatch 200B amplifier/Digidata 1440A 
acquisition system using pCLAMP 10.4 software (Molecular Devices). Whole-cell currents were elicited 
by 40-ms pulses from –90 mV up to +50 mV in 10-mV increments at the holding potential of  –90 mV. 
Paired-pulse protocols for INa activation, inactivation, and recovery from inactivation were also performed. 
After baseline measurement, CyPPA (10 μmol/l) was added and another set of  data was collected. In addi-
tion, we also performed dose-response experiments by adding CyPPA with different concentrations rang-
ing from 0.1 to 30 μmol/l. Voltage-dependent INa and dose-response curves were fitted by pCLAMP 10.2 
(Molecular Devices) and custom-made software. INa was recorded at room temperature.
Confocal calcium imaging. Ventricular cardiomyocytes were centrifuged and resuspended in Ca2+-
free Tyrode’s solution. The Ca2+ indicator dye Fluo-4AM (Invitrogen) was loaded for 20 minutes fol-
lowed by centrifugation and resuspended in Tyrode’s solution with 1.8 mM Ca2+. The dye-loaded myo-
cytes were then placed in a chamber on the stage of  an inverted microscope (Leica TCS SP8 LSCM) 
fitted with a ×40 1.42 NA oil immersion objective. Myocytes were stimulated via 2 platinum electrodes 
on either side of  the bath at 0.5 Hz. The Fluo-4AM was excited at 488 nm wavelength with an argon/
krypton laser. Emission wavelengths above 510 nm were detected by photomultiplier. Fluorescence 
intensity space-time recordings with electrical stimulation were acquired in the line-scan mode (1.69 
ms/line) along the longitudinal axis of  the myocytes. After baseline recording, CyPPA (10 μmol/l) 
and apamin (100 nmol/l) were sequentially added. The normalized fluorescence signal (F/F0) of  AP-
induced calcium transient was analyzed.
RNA preparation and qPCR. The ventricular tissues were dissected from the epicardium of  RVOT and 
LVB, cut into small pieces in RNAlater (Applied Biosystems/Ambion) and immersed at 4°C overnight, 
then stored at –80°C. Total RNA was extracted from the tissues using random primers with RNAque-
ous 4PCR kit (Applied Biosystems/Ambion). cDNA was synthesized from 100 ng total RNA for each 
sample using an iScript Select cDNA Synthesis Kit (Bio-Rad). qPCR was performed using iQ SYBR Green 
Supermix with iCycler (Bio-Rad). Specific primers for SK3 were sense 5′-TTGCCCAACTCCAGAGC-3′ 
and antisense 5′-CAAGCAAGTGGTCATTGAGATTTA-3′ (47). The general protocol for amplification 
was 95°C for 20 seconds, 58°C for 20 seconds, and 72°C for 20 seconds, for 40 cycles. PCR products were 
analyzed in agarose gels, and the amplicons were gel purified with QIAquick Gel Extraction Kit (QIA-
GEN). The sequentially diluted SK3 amplicons were used for standard curves. Data were collected by 
MyiQ Software (Bio-Rad), and analyzed using the threshold cycle (Ct) relative quantification method. The 
glyceraldehyde 3-phosphate dehydrogenase (GAPDH) reference gene was used for normalizing the data. 
2–ΔCt corresponded to the ratio of  SK3 versus GAPDH. The primers for GAPDH were sense 5′-CCATG-
GAGAAGGCCGGGG-3′ and antisense 5′-CGAAGTGGTCGTGGATGAC-3′ (6).
In vivo surface ECG recording. In vivo surface ECG recording was performed in 1 male and 1 female rabbit. 
Anesthesia was induced by isoflurane (2%–5%) inhalation. Ketamine (5–10 mg/kg) and xylazine (3–5 mg/
kg) were mixed and administered by i.v. injection to maintain sedation. After anesthesia, the rabbits were intu-
bated and ventilated (45 breaths/min, 15 ml/kg). The rabbits were shaved and a 9-lead ECG (V1-V6, I, II, and 
III) was continuously recorded throughout the entire experiment by needle electrodes. Rectal temperature was 
continuously monitored. We first recorded the ECG at normothermia (around 38.3°C). Hypothermia was 
then induced by a temperature-controlled water blanket. Alcohol was sprayed on the abdomen to speed up the 
cooling process. The cooling system was turned off  when the rectal temperature reached 34.0°C. The rectal 
temperature continued to fall by 1°C to 2°C afterwards. Hypothermia at 32.0°C ± 0.5°C was maintained for 
15 minutes followed by a single dose of  apamin (40 μg, i.v.). Fifteen minutes after apamin injection, the rab-
bits were rewarmed by water blanket till the body temperature gradually raised to baseline. At the completion 
of  rewarming, the rabbit was euthanized with sodium pentobarbitone overdose (160 mg/kg, i.v.).
Statistics. Continuous variables are expressed as mean ± SEM. Paired Student’s t tests were used to 
compare 2 variables (such as the number of  phase singularities in the RV and the LV) from the same heart. 
Unpaired t tests were used to compare variables between 2 groups (such as J point amplitude between 
females and males). One-way ANOVAs with Tukey’s post hoc test were used to compare the means among 
3 or more different variables (such as the numbers of  SVF at baseline, after CyPPA, and after apamin). 
Two-way ANOVAs with Bonferroni’s post hoc test were used to compare variables among different time 
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points (such as APD25 at baseline, after CyPPA, and after apamin), which measured at different PCL. A 
2-sided P value of  less than 0.05 was considered statistically significant.
Study approval. All animal studies were approved by the IACUC of  Indiana University School of  Medi-
cine, and conformed to the Guide for the Care and Use of  Laboratory Animals (NIH).
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